ALC

ALC

Alcon Inc. Ordinary Shares

$89.120+-0.000 (-0.000%)

Reaalajas hind

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$89.120

Kõrge

$89.120

Madal

$89.120

Maht

1.65M

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Seotud uudised

BusinessWire

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease

In pivotal Phase 3 trials, TRYPTYR demonstrated rapid natural tear production as early as Day 11-2 TRYPTYR is a first-in-class TRPM8 receptor agonist that rapidly stimulates natural tear production in patients with

Vaata rohkem
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
Analyst Upgrades

Needham Reiterates Buy on Alcon, Maintains $110 Price Target

Needham analyst David Saxon reiterates Alcon with a Buy and maintains $110 price target.

Vaata rohkem
Needham Reiterates Buy on Alcon, Maintains $110 Price Target